000 01102 a2200313 4500
005 20250515043014.0
264 0 _c20070109
008 200701s 0 0 jpn d
022 _a0047-1852
040 _aNLM
_beng
_cNLM
100 1 _aIoka, Takashi
245 0 0 _a[Erythropoietin-induced hypertension].
_h[electronic resource]
260 _bNihon rinsho. Japanese journal of clinical medicine
_cSep 2006
300 _a513-6 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntihypertensive Agents
_xtherapeutic use
650 0 4 _aBlood Volume
650 0 4 _aDiagnosis, Differential
650 0 4 _aErythropoietin
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aHypertension
_xchemically induced
650 0 4 _aKidney Failure, Chronic
650 0 4 _aPlatelet Aggregation Inhibitors
_xtherapeutic use
650 0 4 _aRenin-Angiotensin System
_xdrug effects
650 0 4 _aRisk Factors
650 0 4 _aVascular Resistance
700 1 _aKusano, Eiji
773 0 _tNihon rinsho. Japanese journal of clinical medicine
_gvol. Suppl 3
_gp. 513-6
999 _c16599595
_d16599595